Now where do we STAND with crizanlizumab?

被引：0

作者：

Mendez-Marti, Sebastian ^{[1
]}

Thein, Swee Lay ^{[1
]}

机构：

[1] NHLBI, Sickle Cell Branch, Bethesda, MD 20892 USA

来源：

LANCET HAEMATOLOGY | 2025年 / 12卷 / 04期

关键词：

PAIN;

D O I：

10.1016/S2352-3026(25)00033-X

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：e232 / e233

页数：2

共 10 条

[1] Crizanlizumab Versus Placebo, with or without Hydroxyurea/Hydroxycarbamide, in Adolescent and Adult Patients with Sickle Cell Disease and Vaso-Occlusive Crises: A Randomized, Double-Blind, Phase III Study (STAND) [J].

Abboud, Miguel R. ;

Howard, Jo ;

Cancado, Rodolfo ;

Smith, Wally R. ;

Guvenc, Birol ;

Espurz, Noemi ;

Weill, Marine ;

de Montalembert, Mariane .

BLOOD, 2019, 134

[2]

[Anonymous], 2019, FDA approves crizanlizumab-tmca for sickle cell disease

[3]

[Anonymous], 2024, ClinicalTrials.gov

[4] Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease [J].

Ataga, K. I. ;

Kutlar, A. ;

Kanter, J. ;

Liles, D. ;

Cancado, R. ;

Friedrisch, J. ;

Guthrie, T. H. ;

Knight-Madden, J. ;

Alvarez, O. A. ;

Gordeuk, V. R. ;

Gualandro, S. ;

Colella, M. P. ;

Smith, W. R. ;

Rollins, S. A. ;

Stocker, J. W. ;

Rother, R. P. .

NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (05) :429-439

[5]

European Medicines Agency, 2017, EPAR summary for the public, EMA/567879/2017

[6] Initial Safety and Efficacy Results from the Phase II, Multicenter, Open-Label Solace-Kids Trial of Crizanlizumab in Adolescents with Sickle Cell Disease (SCD) [J].

Heeney, Matthew M. ;

Rees, David C. ;

De Montalembert, Mariane ;

Odame, Isaac ;

Brown, R. Clark Clark ;

Wali, Yasser ;

Thu Thuy Nguyen ;

Du Lam ;

Pfender, Nadege ;

Kanter, Julie .

BLOOD, 2021, 138

[7] Primary Analysis of Spartan: A Phase 2 Trial to Assess the Efficacy and Safety of Crizanlizumab in Patients with Sickle Cell Disease Related Priapism [J].

Idowu, Modupe ;

DeBaun, Michael R. ;

Burnett, Arthur ;

Darbari, Deepika S. ;

Adam, Soheir ;

Anderson, Alan Randall ;

Kanter, Julie ;

Billett, Henny H. ;

Liles, Darla K. ;

Nickel, Robert S. ;

Decastro, Laura M. ;

Andemariam, Biree ;

Blyden, Gershwin Theophilus ;

Heeney, Matthew M. ;

Ramadas, Poornima ;

McLemore, Morgan L. ;

Kolekar, Yogita ;

Laine, Dramane ;

Paulose, Jincy ;

Sarkar, Rajendra ;

Vignogna, Mary Beth ;

El Rassi, Fuad .

BLOOD, 2023, 142

[8] Pharmacokinetics, pharmacodynamics, safety, and efficacy of crizanlizumab in patients with sickle cell disease [J].

Kanter, Julie ;

Brown, R. Clark ;

Norris, Cynthia ;

Nair, Santosh M. ;

Kutlar, Abdullah ;

Manwani, Deepa ;

Shah, Nirmish ;

Tanaka, Chiaki ;

Bodla, Shankaranand ;

Sanchez-Olle, Gessami ;

Albers, Urs ;

Liles, Darla .

BLOOD ADVANCES, 2023, 7 (06) :943-952

[9] P-selectin mediates the adhesion of sickle erythrocytes to the endothelium [J].

Matsui, NM ;

Borsig, L ;

Rosen, SD ;

Yaghmai, M ;

Varki, A ;

Embury, SH .

BLOOD, 2001, 98 (06) :1955-1962

[10] Daily assessment of pain in adults with sickle cell disease [J].

Smith, Wally R. ;

Penberthy, Lynne T. ;

Bovbjerg, Viktor E. ;

McClish, Donna K. ;

Roberts, John D. ;

Dahman, Bassarn ;

Aisiku, Imoigele P. ;

Levenson, James L. ;

Roseff, Susan D. .

ANNALS OF INTERNAL MEDICINE, 2008, 148 (02) :94-101

← 1 →